Wierzba Waldemar, Śliwczyński Andrzej, Karnafel Waldemar, Gujski Mariusz, Słodki Maciej, Lusawa Aleksandra, Pinkas Jarosław
University of Humanities and Economics, Lodz, Poland.
Medical University of Warsaw, Warsaw, Poland.
Arch Med Sci. 2020 May 4;18(2):314-319. doi: 10.5114/aoms.2020.94955. eCollection 2022.
End-stage renal disease (ESRD) is an important complication of diabetes, which is the leading cause of ESRD worldwide. The aim of the study was a comparative analysis of all-cause mortality in patients with ESRD with diagnosed diabetes mellitus (DM) and no diagnosed DM.
Data for the analysis were obtained from the resources of the Polish National Health Fund, and they concerned patients with end-stage renal disease from the entire population of Polish patients in the period from 1.01.2011 to 31.12.2013. In addition, the period from 1.01.2012 to 31.12.2012 was analysed for two subpopulations: diabetic and non-diabetic patients.
The all-cause mortality in patients with end-stage renal disease in Poland per 100,000 representatives of the general population was 17.7, 15.9, and 12.50 persons in 2011, 2012, and 2013, respectively. The all-cause mortality rates for patients with ESRD and diabetes in Poland in 2012 were more than 15 times higher, for both men and women, than the all-cause mortality rates for non-diabetic patients with ESRD. Mortality in the study group of diabetic men with ESRD amounted to 147.59 ±29.07/100,000 men, whereas in the study group of diabetic women with ESRD it was 105.13 ±26.77/100,000 women. Regarding non-diabetic men with ESRD and non-diabetic women with ESRD, mortality amounted to 9.58 ±6.29/100,000 and 6.87 ±2.27/100,000 men and women, respectively.
The occurrence of diabetes in patients with ESRD significantly increases the risk of death compared to patients with ESRD without diabetes.
终末期肾病(ESRD)是糖尿病的一种重要并发症,糖尿病是全球范围内ESRD的主要病因。本研究的目的是对已诊断糖尿病(DM)和未诊断DM的ESRD患者的全因死亡率进行比较分析。
分析数据来自波兰国家卫生基金的资源,涉及2011年1月1日至2013年12月31日期间波兰全体患者中的终末期肾病患者。此外,还对2012年1月1日至2012年12月31日期间的两个亚组进行了分析:糖尿病患者和非糖尿病患者。
波兰终末期肾病患者每10万名普通人群中的全因死亡率在2011年、2012年和2013年分别为17.7人、15.9人和12.50人。2012年波兰ESRD合并糖尿病患者的全因死亡率,无论男性还是女性,均比非糖尿病ESRD患者的全因死亡率高出15倍以上。ESRD合并糖尿病男性研究组的死亡率为147.59±29.07/10万男性,而ESRD合并糖尿病女性研究组的死亡率为105.13±26.77/10万女性。对于ESRD非糖尿病男性和ESRD非糖尿病女性,死亡率分别为9.58±6.29/10万男性和6.87±2.27/10万女性。
与无糖尿病的ESRD患者相比,ESRD患者中糖尿病的发生显著增加了死亡风险。